Intuitive Surgical, Inc. $ISRG Stock Bought by Legacy Wealth Asset Management LLC

Legacy Wealth Asset Management LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,857 shares of the medical equipment provider’s stock after acquiring an additional 1,876 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Intuitive Surgical were worth $1,975,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of ISRG. LifeGoal Investments LLC purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $335,000. Mn Services Vermogensbeheer B.V. raised its stake in Intuitive Surgical by 1.2% during the third quarter. Mn Services Vermogensbeheer B.V. now owns 104,678 shares of the medical equipment provider’s stock worth $42,565,000 after purchasing an additional 1,200 shares during the period. GAMMA Investing LLC raised its stake in Intuitive Surgical by 19.8% during the third quarter. GAMMA Investing LLC now owns 8,334 shares of the medical equipment provider’s stock worth $3,389,000 after purchasing an additional 1,378 shares during the period. Bell Asset Management Ltd acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $2,684,000. Finally, CoreCap Advisors LLC boosted its holdings in shares of Intuitive Surgical by 2.8% in the 3rd quarter. CoreCap Advisors LLC now owns 1,299 shares of the medical equipment provider’s stock valued at $528,000 after purchasing an additional 35 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ISRG. TD Cowen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. Stifel Nicolaus reduced their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Oppenheimer raised Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price target for the company in a research report on Wednesday, August 12th. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research note on Thursday, July 30th. Finally, Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $502.53.

Insider Activity at Intuitive Surgical

In other news, Director Amy Ladd sold 72 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director directly owned 179 shares of the company’s stock, valued at approximately $70,364.90. The trade was a 28.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the sale, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. This trade represents a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 0.2%

Shares of Intuitive Surgical stock opened at $415.41 on Friday. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88. The stock has a market cap of $146.76 billion, a price-to-earnings ratio of 47.58, a price-to-earnings-growth ratio of 3.13 and a beta of 1.46. The company has a fifty day moving average price of $384.95 and a 200 day moving average price of $411.17.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm’s revenue was up 18.4% compared to the same quarter last year. During the same period last year, the company posted $1.81 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays initiated coverage with an Overweight rating and later upgraded the stock to Strong Buy, signaling confidence in Intuitive Surgical’s market position and long-term growth prospects. Barclays starts coverage of Intuitive Surgical stock at Overweight
• Positive Sentiment: Piper Sandler also rated ISRG Buy, adding to the cluster of bullish opinions from Wall Street analysts. Intuitive Surgical gets a Buy from Piper Sandler
• Positive Sentiment: Intuitive Surgical’s single-port robotic platform is gaining traction, with rising procedure volumes, utilization and system placements, as well as expanding indications and international adoption. That platform could become a major additional growth franchise. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts’ average recommendation remains bullish, but commentary cautions that sell-side ratings can be overly optimistic and should not be treated as a standalone investment signal. Investors are focused on the upcoming earnings release, which is expected to show year-over-year revenue and earnings growth. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: Competition is becoming a larger concern. Jim Cramer highlighted Johnson & Johnson and other entrants as threats, while investors continue to debate whether ISRG’s premium valuation adequately reflects its strong competitive position and recurring-revenue model. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.